# Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

> **NCT02317705** · PHASE2 · COMPLETED · sponsor: **On Target Laboratories, LLC** · enrollment: 48 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** OTL38
- **DEVICE:** Near infrared camera imaging system
- **PROCEDURE:** Laparotomy

## Key facts

- **NCT ID:** NCT02317705
- **Lead sponsor:** On Target Laboratories, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317705, "Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02317705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*